HomeNGEN • NASDAQ
add
NervGen Pharma Corp
Previous close
$4.21
Day range
$4.04 - $4.22
Year range
$3.51 - $6.30
Avg Volume
176.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.40M | -5.90% |
Net income | -26.91M | -212.58% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.39M | 5.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.07M | 27.81% |
Total assets | 23.21M | 19.11% |
Total liabilities | 19.73M | 16.70% |
Total equity | 3.48M | — |
Shares outstanding | 80.93M | — |
Price to book | 105.25 | — |
Return on assets | -88.24% | — |
Return on capital | -5,551.41% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.91M | -212.58% |
Cash from operations | -6.40M | -74.80% |
Cash from investing | 25.23K | -0.00% |
Cash from financing | 16.74M | 5,300.60% |
Net change in cash | 10.71M | 386.19% |
Free cash flow | 1.11M | 300.27% |
About
Founded
2017
